At a glance
ClinicalIndex Comparison RecordN/ACompleted· 123 enrolled
Drug / intervention
Assurant® Cobalt Iliac Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The ACTIVE (Use of the Assurant® Cobalt Iliac Stent System in the Treatment of Iliac Vessel Disease) Study Using the Medtronic Assurant Cobalt Iliac Balloon-Expandable Stent System
In Brief
A clinical study evaluating Assurant® Cobalt Iliac Stent System for Peripheral Vascular Disease. Completed, enrolled 123 participants across 2 sites.
Detailed Summary
The objective of this study is to evaluate the safety and efficacy of the Assurant Cobalt Iliac Stent System in the treatment of de novo and restenotic lesions in iliac arteries of subjects with Peripheral Artery Disease (PAD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2008
Enrollment StartOct 2008
Primary CompletionFeb 2011
Study CompletionSep 2013
TodayJul 2026
First PostedSep 16, 2008
Enrollment StartOct 1, 2008
Primary CompletionFeb 1, 2011
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.8 years ago
Interventions
Assurant® Cobalt Iliac Stent Systemdevice
Iliac Stenting